RECENT ADVANCES IN THE 5Q- SYNDROME
The 5q- syndrome is the most distinct of the myelodysplastic syndromes (MDS) and patients with this disorder have a deletion of chromosome 5q [del(5q)] as the sole karyotypic abnormality. Several genes mapping to the commonly deleted region of the 5q- syndrome have been implicated in disease pathoge...
Saved in:
| Main Authors: | Andrea Pellagatti, Jacqueline Boultwood |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2015-05-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/2286 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
by: Julie Schanz, et al.
Published: (2015-04-01) -
Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
by: Pasquale Niscola
Published: (2014-08-01) -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
by: Antonella Vaccarino, et al.
Published: (2016-10-01) -
Cytogenetic profile and risk of transformation to acute myeloid leukemia (AML) in Indonesian patients with myelodysplastic syndrome (MDS): a pilot study [version 1; peer review: 2 approved]
by: Yuniar Harris Prayitno, et al.
Published: (2024-03-01) -
THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT
by: Paul Richardson, et al.
Published: (2010-05-01)